Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Le Page

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of the Neurological Sciences|February 10, 2009
Long-term experience with induction treatment regimens in multiple sclerosisEmmanuelle Le Page, Gilles Edan
Drugs|September 19, 2023
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?Gilles Edan, Emmanuelle Le Page
La Revue Du Praticien|September 5, 2006
[Drug therapy in multiple sclerosis]Emmanuelle Le Page, Gilles Edan
CNS Drugs|May 10, 2013
Induction therapy for patients with multiple sclerosis: why? When? How?Gilles Edan, Emmanuelle Le Page
Journal of the Neurological Sciences|July 21, 2004
Rationale for the use of mitoxantrone in multiple sclerosisGilles Edan, Sean Morrissey, Emmanuelle Le Page
Frontiers in Neurology|March 6, 2023
Pregnancy-related healthcare utilization among women with multiple sclerosisMarie Mainguy, Emmanuelle Le Page, Laure Michel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 25, 2006
Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assayCatherine Massart, Jacqueline Gibassier, Joël Oger, et al.
Expert Review of Neurotherapeutics|April 1, 2022
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in FranceSoline Leblanc, Mathilde Lefort, Emmanuelle Le Page, et al.
Journal of Neurology|February 22, 2015
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational studyEmmanuelle Le Page, Véronique Deburghgraeve, Marie-Antoinette Lester, et al.
Brain : a Journal of Neurology|April 29, 2010
Evidence for a two-stage disability progression in multiple sclerosisEmmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of the Neurological Sciences|February 10, 2009
Long-term experience with induction treatment regimens in multiple sclerosisEmmanuelle Le Page, Gilles Edan
Drugs|September 19, 2023
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?Gilles Edan, Emmanuelle Le Page
La Revue Du Praticien|September 5, 2006
[Drug therapy in multiple sclerosis]Emmanuelle Le Page, Gilles Edan
CNS Drugs|May 10, 2013
Induction therapy for patients with multiple sclerosis: why? When? How?Gilles Edan, Emmanuelle Le Page
Journal of the Neurological Sciences|July 21, 2004
Rationale for the use of mitoxantrone in multiple sclerosisGilles Edan, Sean Morrissey, Emmanuelle Le Page
Frontiers in Neurology|March 6, 2023
Pregnancy-related healthcare utilization among women with multiple sclerosisMarie Mainguy, Emmanuelle Le Page, Laure Michel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 25, 2006
Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assayCatherine Massart, Jacqueline Gibassier, Joël Oger, et al.
Expert Review of Neurotherapeutics|April 1, 2022
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in FranceSoline Leblanc, Mathilde Lefort, Emmanuelle Le Page, et al.
Journal of Neurology|February 22, 2015
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational studyEmmanuelle Le Page, Véronique Deburghgraeve, Marie-Antoinette Lester, et al.
Brain : a Journal of Neurology|April 29, 2010
Evidence for a two-stage disability progression in multiple sclerosisEmmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, et al.
Pageof 7